InvestorsHub Logo
Followers 5
Posts 113
Boards Moderated 0
Alias Born 01/19/2015

Re: None

Monday, 05/25/2020 5:46:09 PM

Monday, May 25, 2020 5:46:09 PM

Post# of 232145
RA Capital Covid-19 Analyse
Who we are:
RA Capital funds and builds healthcare and life science companies

https://www.racap.com/covid-19

Therapeutics (Cytodyn in green rectangle and looks like a frontrunner):
There are not so many alternatives anymore, after the hydroxychloroquine (suspended from trials) and remdesevir (no significant results or improvements), especially without side effects (eidd 2801 and all oral medicine) it gets very dark and scaling is not that easy (mesoblast)!



Overall analysis:
https://www.racap.com/media/Covid-19/COVID-19_05222020_F_Thumbnail.png?v=tqQ5pOl-0msFNUBskKsKb3JnZyTa69-O0hXAIx6ImKk
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News